Table 1 Patient characteristics and adverse events during portable brain MRI scan
Age (years) | Sex | BMI | ECMO indication | Cannulation strategy | Neurologic symptoms | MRI time (min) | HCT finding | MRI finding | ABI management | Adverse events* | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 47 | Male | 30.5 | COVID-19 ARDS | Fem-IJ (VV-ECMO) | Coma under sedation | 40 | Acute left occipital ischemic stroke with hemorrhagic conversion | Acute left occipital ischemic stroke | Anticoagulation held and restarted with serial imaging studies | One self-limited ECMO suction event |
2 | 45 | Male | 32.5 | COVID-19 ARDS | Fem-IJ (VV-ECMO) | Coma under sedation | 43 | No acute findings | None | Not applicable | None |
3 | 55 | Female | 27.1 | Cardiogenic shock with PE | Fem–Fem (VA-ECMO) | Coma under sedation | 34 | No acute findings | Acute right basal ganglia ischemic infarct | Anticoagulation held and restarted with serial imaging studies | Frequent ECMO suction events, received intravenous fluids; improved with repositioning patient* |